Recent Finacing
Recent Raise
Ausoboxin develops ACXEL, a digital microfluidic cell-manipulation platform on large-area electronics that automates high-integration single-cell experimental protocols for research, cell-line and cell therapy development, and synthetic biology.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
